MRCP revision battle 43.1: Post renal-transplant complications
MRCP revision battle 43.2: Polycystic kidney disease and renal cysts
MRCP revision battle 43.3: Renal tubular acidosis
MRCP revision battle 43.4: Haematuria
MRCP revision battle 43.5: Renal calculi
MRCP revision battle 43.6: Focal Segmental Glomerulonephritis
MRCP revision battle 43.7: Acute renal failure
MRCP revision battle 43.1: Post renal-transplant complications
A kidney transplant can give a renal patient their life back as it frees them from endless dialysis sessions. However, with kidney transplants come the risk of rejection/failure, complications and the burden of immunosupression...
Rejection
Acute rejection (less than 6 months post graft) presents as rising creatinine, possibly with fever and graft pain. Biopsy would show immune cell infiltration. Treatment is with high dose IV methylprednislone
Chronic rejection (greater than 6 months post graft) presents as gradually rising creatinine and proteinuria. Biopsy would show fibrosis. There is no effective treatment.
Overall graft survial is around 90% at 1 yr, 70% at 5 yrs and 50% at 10 yrs.
Non-renal complications
- Non-Hogkins Lymphoma - 20-50x increased risk due to ciclosporin use
- Skin cancer - 5-20x increased risk due to azothioprine
- Widespread warts/fungi/herpes zoster due to T cell supression by immunosupressives
- Cardiovascular disease - 10-20x increased risk
- CMV - give oral ganciclovir
- Pneumocystis carini pneumonia - give cotrimoxazole prophylaxis for first 6 months post transplant
- if previous TB give isoniazid for first year
- gout
- Diabetes - develops in 3-5%, ?due to tacrolimus
The common immunosupressants
- Ciclosporin
- inhibits T cell phosphatase calcineurin
- can cause tremor, hypertension, gum hypertrophy
- Tacrolimus
- decreases T cell activation
- ?risk of diabeets
- Azothioprine
- contraindicated with allopurinol as risk of life-threatening bone marrow supression
- is an anti-proliferation drug
- TPMT test can be used to look for patients prone to toxicity
- side effects include bone marrow supression and pancreatitis.
- Mycophenolate
- anti-proliferative
- causes diarrhoea
- Sirolimus
- blocks IL2 so inhibits T cell division
- can provoke hyperlipidaemia
Now lets move on to polycystic kidney disease....